Other intranasal treatment opportunities
In those globally challenging times, SipNose offers its innovative intranasal delivery product as a superior delivery of anti-viral agents (virucides) and vaccines. SipNose is seeking to collaborate with companies who have effective drugs or formulations, and which joined the effort to cope with the worldwide coronavirus pandemic.
Responses to the COVID-19 pandemic have focused on three areas:
- Therapeutic treatments for those infected
- Vaccine development to protect against future infection
- Environmental and societal strategies to reduce retransmission rates
SipNose is open to collaborate with companies who are interested in uniting efforts to cope with the worldwide coronavirus pandemic.